Jump to content

Brimonidine Phase II Study Group


Recommended Posts

British Journal of Dermatology, 2012 166, pp 633–641

Once-daily topical brimonidine tartrate gel 0Æ5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies

J. Fowler, M. Jarratt, A. Moore, K. Meadows, A. Pollack, M. Steinhoff, Y. Liu and M. Leoni, on behalf of the Brimonidine Phase II Study Group

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Create New...

Important Information

Terms of Use